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Background: The contribution of childhood obesity to adult type 2 
diabetes (T2DM), not through adult adiposity, as well as the causal 
pathways through which childhood obesity increases adult T2DM 
risk are not well understood. This study investigated the contribu-
tion of childhood obesity to incident T2DM including pathways not 
through adult adiposity, and explored whether race modified this con-
tribution.
Methods: We used data from the Virtual Los Angeles Cohort, an 
agent-based longitudinal birth cohort composed of 98,230 simu-
lated individuals born in 2009 and followed until age 65 years. We 
applied the parametric mediational g-formula to the causal mediation 
analysis investigating the impact of childhood obesity on the devel-
opment of adult T2DM.
Results: The marginal adjusted odds ratio (aOR) for the total effect 
of childhood obesity on adult T2DM was 1.37 (95% CI = 1.32, 1.46). 
Nearly all the effect of childhood obesity on adult T2DM was mostly 
attributable to pathways other than through adult obesity; the aOR 
for the pure direct effect was 1.36 (95% CI = 1.31, 1.41). In all racial 
subpopulations, a similar 3% of the total effect of childhood obesity 
on adult T2DM was attributable to its effect on adult obesity.
Conclusions: Childhood obesity remains a risk factor for adult 
T2DM separate from its effects on adult obesity. This study empha-
sizes the potential benefits of early interventions and illustrates that 
agent-based simulation models could serve as virtual laboratories for 
exploring mechanisms in obesity research.
Keywords: Agent-based model; Cohort; Diabetes; G-formula; Me-
diation; Obesity; Simulation; Synthetic
(Epidemiology 2019;30: S101–S109)
For decades, obesity has been recognized as a major public health problem affecting millions of Americans, including 
the most vulnerable segment of the population, namely children, 
adolescents, and lower-income minorities.1 Obesity in adulthood 
is a known risk factor for type 2 diabetes (T2DM)2 and thus the 
increasing rates of obesity have substantially played a critical 
role in the epidemic of T2DM.3 Studies have shown that com-
pared with normal-weight children, obese children are at a higher 
risk of becoming obese adults4 and that obese children who re-
main obese in adulthood are at increased risk for adult T2DM 
compared with obese children who become nonobese in adult-
hood.2,5 This suggests that childhood obesity may be a risk factor 
for adult T2DM through adult adiposity and that the increased 
risk in T2DM due to obesity may be due to the tracking of ex-
cess weight from childhood into adulthood. However, how and 
by which mechanisms this occurs remains relatively unexplored.
In fact, it is unclear whether childhood obesity affects 
adult T2DM independently of adulthood adiposity.6 More 
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generally, the causal pathways through which childhood obe-
sity increases adult T2DM risk are not well understood. The 
ability to open such a black box can assist policymakers in 
identifying causal pathways and targeting the ones that would 
have the greatest impact on reducing T2DM. Investigations of 
this sort entail mediation and interaction analyses.7 In the past, 
methods such as the so-called difference method have been 
used to estimate mediated (or indirect) effects in the explo-
ration of such mechanisms but they have been unsatisfactory 
as they can lead to distorted results.8,9 More recently though, 
novel methods such as the parametric g-formula10 have 
allowed researchers to disentangle the path-specific effects of 
exposures or interventions.11–13 Although powerful, the appli-
cation of such methods are often limited to single existing ob-
servational prospective studies.14,15
Today, scientific progress has allowed researchers to cre-
ate complex synthetic populations informed by best evidence, 
to explore mechanisms, forecast disease burden and evaluate 
intervention impacts.15–17 An example of such a technique is 
an agent-based model (ABM), defined as a computer simula-
tion model representing a system or reality that incorporates 
evidence about individuals’ behaviors and their physical and 
social environment and could serve as virtual laboratory for 
testing hypotheses and running experiments.18,19 Given the 
paucity of long-running cohorts and trials implemented when 
obesity reached epidemic proportions among children, devel-
oping a virtual cohort where individuals are followed from 
birth to adulthood to study obesity and its long-term effects 
can be a suitable alternative. However, the use of the para-
metric g-formula to untangle complex mechanisms within 
such synthetic cohort has not yet been explored. A recent 
study compared ABMs and the parametric g-formula for de-
cision-making and observed that ABMs can result in biased 
estimates when input parameters—(e.g., baseline risk) are 
transported from one population to another—owing to (1) the 
nontransportability of such parameters or to (2) the lack of 
causal interpretation of regression coefficients.15
In the present study, we propose to address these short-
comings by using both an ABM and the parametric g-formula 
in conjunction, to investigate the contribution of childhood 
obesity to incident T2DM that is independent of its effect on 
adult adiposity (“direct effect”), and determine if race modi-
fies this contribution. In particular, we will estimate consistent 
path-specific effects and decompose the effects of childhood 
obesity on T2DM by applying the parametric g-formula within 
a prospective synthetic cohort.
METHODS
Structure of the Agent-based Model
The Virtual Los Angeles (ViLA) Obesity Model is an 
agent-based model of obesity and T2DM in U.S. individuals 
born in Los Angeles, CA, and followed from birth to age 65 
years (see eAppendix; http://links.lww.com/EDE/B571, for 
details). Briefly, we simulated 98,230 simulated individuals or 
agents spread out in 235 simulated neighborhoods from birth 
to age 65 years in 10 discrete time steps. Each agent was born 
in 2009 in a specific neighborhood of Los Angeles County and 
could exhibit healthy and unhealthy behaviors. At each time 
step, the model updated the individuals’ behaviors, their body 
mass indices, and T2DM status as a function of the agent’s 
current state. The ViLA-Obesity Model was also used to fore-
cast obesity and T2DM incidence and prevalence among U.S. 
individuals born in Los Angeles County (R. A. Nianogo, MD, 
MPH, PhD, O. A. Arah, MD, MSc, MPH, DSc, PhD, unpub-
lished data, 2017). This study was deemed not a Human Sub-
ject Research by the UCLA IRB.
Measures and Variables
Exposure: Childhood Obesity Between Age 6 and 12 
Years
The exposure of interest was childhood obesity in middle 
childhood between the age of 6 and 12 years old. Childhood 
obesity was defined using the World Health Organization 
(WHO) guidelines on the basis of the body mass index (BMI) 
Z scores calculated using SAS code provided by the US Cen-
ters for Disease Control and Prevention.20 We used Z scores 
instead of percentiles because Z scores are comparable across 
ages and sex and are better for longitudinal assessments.21 A 
child with a BMI Z score (BMIz) less than −2 was classified as 
underweight; a BMIz greater or equal to −2 but less than 1 was 
classified as normal weight; a BMIz greater or equal to 1 but 
less than 2 was classified as overweight; and a BMIz greater or 
equal to 2 was classified as obese.22
Mediators: Adult Obesity Between Age 30 and 39 
Years and Physical Activity Between Age 25 and 39 
Years
The primary mediator of interest was adult obesity be-
tween the age of 30 and 39 years (binary variable). Using 
the WHO guidelines, an individual with a BMI less than 
18.5 was classified as underweight; a BMI greater or equal 
to 18.5 but less than 25 was classified as normal weight; a 
BMI greater or equal to 25 but less than 30 was classified as 
overweight; and a BMI greater or equal to 30 was classified 
as obese.23
The secondary mediator of interest was the adult phys-
ical activity level (i.e., recommended moderate-to-vigor-
ous physical activity) between age 25 and 39 years (binary 
variable).
Outcome: Adult T2DM Between Age 40 and 49 Years
The outcome of interest was incident adult T2DM be-
tween the ages of 40 and 49 years (binary variable).
Covariates and Intermediate Health Behaviors
The following variables were considered in this 
study: individuals’ sociodemographics (age, sex, socioec-
onomic status, marital status, race), individuals’ behaviors 
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(sugar-sweetened beverage consumption, physical activity, 
fruit and vegetable consumption, fast-food consumption, 
smoking, alcohol consumption), neighborhood walkability, 
and neighborhood access to parks. These variables were bi-
nary with the exception of age, which was continuous.
Statistical Analyses
Causal Graph and G-computation Algorithm
We represented our assumptions about the underlying 
pathways from childhood obesity to adult T2DM and the re-
lations among covariates, exposure, mediators, and outcomes 
using a directed acyclic causal diagram24 (Figure 1).
We used g-computation10 to decompose the effect of 
childhood obesity on adult T2DM. This method requires cor-
rect model specification when modeling all covariates and 
may be sensitive to violations of assumptions.25 To conduct 
our causal mediation analysis, it was assumed that there was 
conditional exchangeability (i.e., no-uncontrolled confounding 
assumption), positivity,26 consistency,27 no interference (i.e., 
stable unit treatment value assumption or SUTVA),28 and no 
other sources of bias (i.e., no selection bias, no measurement 
error, and no model misspecification). In the context of medi-
ation analysis, the no-uncontrolled confounding assumption 
consisted of four parts:29,30 (i) no-uncontrolled confounding 
between exposure and outcome, (ii) no-uncontrolled confound-
ing between mediator and outcome, (iii) no-uncontrolled con-
founding between exposure and mediator, and finally (iv) no 
exposure-induced mediator-outcome confounder. In our study, 
the latter assumption (iv) is violated since childhood adiposity 
was allowed to affect subsequent physical activity levels which 
in turn could affect subsequent obesity risk and adult T2DM. 
Fortunately, a recent study has proposed solutions to circum-
vent this problem.30 We briefly described the two estimation 
approaches used to decompose the effect of interest.
Estimation and Effect Decomposition
To circumvent the problem of exposure-induced medi-
ator-outcome confounder (fourth assumption), we applied 
two analytical approaches described in Vanderweele et al.30 
to compute other natural effects and path-specific effects. Let 
A denote childhood obesity at age 6–12 years (i.e., the expo-
sure of interest), M adult obesity at age 30–39 years (i.e., the 
mediator of interest), L adult level of physical activity at age 
25–29 years (i.e., an exposure-induced confounder), V adult 
level of physical activity at age 30–39 years, Y adult T2DM 
at age 40–49 years (i.e., the outcome of interest), and C a set 
of baseline covariates not affected by exposure (Figure 1). For 
any variable W, let W = w, W = 0, W = 1 denote, respec-
tively, the realized mean, reference value, or index value of 
W. We will let Y L M VA a A a A a A a= = = =, , ,  denote, respectively, the 
potential outcomes of Y, L, M, or V had A been set to a. Also, 
YA a M VA a LA a A a LA a= = = = =, ,, ,
 denotes the potential outcome value of Y 
had A been set to a, M to M A a LA a= =,   and V to VA a LA a= =,  .
FIGURE 1. Simplified DAG of the assumptions about the data-generating processes between childhood obesity and type 2 dia-
betes 2. C, Sociodemographics (age, sex, socioeconomic status, marital status); BHV: time-varying behaviors (sugar-sweetened 
beverage consumption, fast-food consumption, fresh fruit and vegetable consumption, smoking, alcohol drinking); OBE: obesity; 
ENV: (Neighborhood Access to Parks, Neighborhood walkability); FHD: family history of type 2 diabetes; MVPA25–29: moderate-
to-vigorous physical activity at age 25–29 years; MVPA30–39: moderate-to-vigorous physical activity at age 30–39 years; OBE30–39: 
Obesity at age 30–39 years; T2DM40–49: type 2 diabetes at age 40–49 years. The bold lines depict the pathways from childhood 
obesity to adult type 2 diabetes. A, General data-generating mechanism from childhood obesity to type 2 diabetes. B, Direct 
natural effect (PDE, TDE); (C) effect OBE6–12→  OBE30–39→  T2DM40–49; (D) indirect natural effect (TIE, PIE); (E) effect OBE6–12→ 
MVPA25–29; MVPA30–39 →  T2DM40–49. DAG indicates directed acyclic graph.
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Recall that M represents adult obesity at age 30–39 
years, L adult level of physical activity at age 25–29 years, 
and V adult level of physical activity at age 30–39 years. In the 
first approach “joint mediator approach,” we considered the 
set Z L V M={ }, ,  jointly (i.e., simultaneously) as the mediator 
of interest. In other words, from childhood obesity to adult 
T2DM there were essentially two pathways: (i) one direct and 
(ii) one indirect that combines pathways through adult obesity 
(M) and pathways through adult physical activity (L, V).
In the second approach, “path-specific approach,” we 
considered adult obesity (M) as the actual mediator of interest. 
Put another way, from childhood obesity to adult T2DM, there 
were essentially three pathways: (i) pathways involving nei-
ther adult obesity nor adult level of physical activity (i.e., A 
→ Y), (ii) effects not involving adult level of physical activity 
(i.e., A → M→ Y), and (iii) effects involving only adult level 
of physical activity (i.e., combination of A → L→ V→ Y, A → 
L→ M→ Y and A → V→ Y) summarized as A → LV→ Y. In the 
second approach, path-specific effects were estimated.
For clarity, the quantities we estimated in this study are 
briefly defined. More extensive definitions and expressions 
can be found in Wang and Arah31 and Vanderweele et al.30
The expressions for the natural decomposition are 
given as follows:
The total effect (TE) measures the overall extent to 
which childhood obesity causes adult T2DM. It was given by 
the following expression:
E E Y YA ATE = −[ ]= =1 0
The pure direct effect (PDE) measures the extent to which 
childhood obesity causes adult T2DM through pathways other 
than through the joint mediator set Z L V M={ }, ,  and was 
given by the following expression:
E E Y YA Z A ZA APDE = −
 = == =1 00 0, ,
The total direct effect (TDE) measures the extent to which 
childhood obesity causes adult T2DM through pathways other 
than through the joint mediator set Z L V M={ }, ,  allowing the 
joint mediator set to simultaneously boost up or tune down 
such effect at the same time. It was given by the following 
expression:
E E Y YA Z A ZA ATDE = −
 = == =1 01 1, ,
The pure indirect effect (PIE) measures the extent to which 
childhood obesity causes adult T2DM through the joint me-
diator set Z L V M={ }, ,  only, not accounting for the possible 
interaction between childhood obesity and the joint mediator 
set Z L V M={ }, , . It was given by the following expression:
E E Y YA Z A ZA APIE = −
 = == =0 01 0, ,
The total indirect effect (TIE) measures the extent to which 
childhood obesity causes adult T2DM through the joint me-
diator set Z L V M={ }, ,  only, but accounting for the possible 
interaction between childhood obesity and the joint mediator 
set Z L V M={ }, , . It was given by the following expression:
E E Y YA Z A ZA ATIE = −
 = == =1 11 0, ,
The controlled direct effect (CDE) measures the extent to 
which childhood obesity causes adult T2DM when fixing the 
joint mediator set at Z specific value for everyone in the pop-
ulation. There are three types of CDEs: (i) the CDEref (CDE at 
the reference level) or CDE when fixing the joint mediator set 
to the reference level of 0 (Z = 0); (ii) the CDEidx (CDE at the 
index level) or CDE when fixing the joint mediator set to the 
index level of 1 (Z = 1); and (iii) the CDEsto (stochastic CDE) 
or CDE when allowing the joint mediator set to attain a cer-
tain controlled distribution in the population (Z z= ). These 
quantities were given by the following expressions:
E E Y YA Z A ZCDEref = − = = = =1 0 0 0, ,
E E Y YA Z A ZCDEidx = − = = = =1 1 0 1, ,
E E Y YA Z z A Z zCDEsto = − = = = =1 0, ,
The expressions for the path-specific effects were also given 
as follows:
The effect neither involving adult obesity nor adult level 
of physical activity (A → Y) was expressed as follows:
E E Y YA Y A M V A M VA LA A LA A LA A LA→ = =
= −

 = = = = = = = =1 00 0 0 0 0 0 0 0, , , ,, , , ,


The effect not involving adult level of physical activity 
(A → M→  Y) was expressed as follows:
E E Y YA M Y A M V A M VA LA A LA A LA A LA→ → = =
= −

=
=
=
=
=
=
=
=
1 11 0 0 0 0 0 0 0, , , ,, , , ,


The effect involving only adult level of physical activity 
(A → LV→  Y) was expressed as follows:
E E Y YA LV Y A M V A M VA LA A LA A LA A LA→ → = =
= −
=
=
=
=
=
=
=
=
1 11 1 1 1 1 0 0 0, , , ,, , , ,




We completed all data preparation, parametric modeling, sim-
ulations, and analysis in SAS version 9.4 (SAS Institute, Inc., 
Cary, NC).
Sensitivity Analysis
We conducted three groups of sensitivity analyses. First, 
we assessed whether the time at which childhood obesity and 
T2DM were assessed impacted our conclusion. Second, we 
varied the potential remission rate of T2DM due to lifestyle 
and weight loss management with or without medication to 
Copyright © 2019 Wolters Kluwer Health, Inc. Unauthorized reproduction of this article is prohibited.
Epidemiology • Volume 30, Suppl 2, November 2019 Role of Childhood Adiposity in Type 2 Diabetes
© 2019 Wolters Kluwer Health, Inc. All rights reserved. www.epidem.com | S105
assess the robustness of our results. This was to account for the 
fact that T2DM could be cured in its early stages.32,33 Third, 
we investigated the direct and mediated effects of childhood 
obesity on prevalent T2DM.
RESULTS
Table 1 describes the baseline and follow-up character-
istics of the simulated cohort. Two-thirds of our population 
were non-White and about one-fourth had an income below 
or at the federal poverty level. Consumption of fast-food was 
found in 75% of children and in about 50% of adults in their 
40s. About one-fourth and one-third of individuals were obese 
in childhood and adulthood, respectively. One in four individ-
uals had T2DM in their 40s.
Table 2 presents the decomposition of the effects of 
childhood obesity on adult T2DM estimated using g-compu-
tation. The marginal adjusted odds ratio (aOR) for the total 
effect of childhood obesity on adult T2DM was 1.37 (95% 
CI = 1.32, 1.46). The results were similar using the joint me-
diator or the path-specific approach. Under both approaches, 
nearly all the effect of childhood obesity on adult T2DM 
was mostly attributable to pathways other than through adult 
obesity (e.g., pure direct effect aOR: 1·36 [95% CI = 1.31, 
1.41]). Only 3% of the total effect of childhood obesity on 
adult T2DM was attributable to childhood obesity affect-
ing adult obesity and subsequently affecting adult T2DM 
(Figure 2).
TABLE 1. Baseline and Follow-up Characteristics of Simulated Individuals in the ViLA-obesity Model (n = 98,230)
Childhood
(6–12)
Adulthood
(30–39)
Adulthood
(40–49)
Age in years (mean, SD) 9 (1.78) 34.52 (2.63) 44.48 (2.63)
Male (%)  49 49
Low income (i.e., below or at FPL) (%) 22 22 22
Married (%) 0 44 44
Non-White (%) 63 63 63
Has family history of type 2 diabetes (%) 8 8 8
Ate fast-food ≥1 times in past week (%) 76 74 52
Physically active at least 1 hour per day (%) 23 27 24
Drank ≥1 glasses of SSB (%) 66 45 23
Eat ≥5 fresh fruits and vegetables (%) 45 54 51
Current smoker (%) 0 12 9
Binge drank alcohol the past month (%) 0 17 13
High neighborhood walkability (%) 28 27 27
High neighborhood access to parks (%) 54 56 55
Body mass index (kg/m2 mean, SD) (20.68) 4.39 27.24 (6.26) 26.24 (6.97)
Obese (%) 24 32 30
Has type 2 diabetes (%) 0 3 25
All categorical variables are binary.
FPL indicates federal poverty level; SSB, sugar-sweetened beverage consumption.
TABLE 2. Decomposition of the Effect of Childhood Obesity 
on Adult Type 2 Diabetes in the ViLA-obesity Model Using 
D-computation in a Marginal Structural Model
Method ORa (95% CI)
Joint mediator approach (MVPA25–29, MVPA30–39,  
OBE30–39) as the joint mediator set
 
  PDE 1.36 (1.31, 1.41)
  TIE 1.01 (1.00, 1.02)
  PIE 1.01 (1.00, 1.02)
  TDE 1.36 (1.31, 1.41)
  CDEsto (marginal) 1.37 (1.37, 1.38)
  CDEref 1.39 (1.33, 1.46)
  CDEidx 1.38 (1.31, 1.44)
  Total Effect 1.37 (1.32, 1.46)
Path-specific approach (OBE30–39 as the actual mediator)  
  Effect involving neither adult obesity nor PA  
(OBE6–12→ T2DM40–49) (PSDE)
1.36 (1.31, 1.41)
  Effect not involving PA (OBE6–12→ OBE30–39→   
T2DM40–49) (PSIE-A)
1.00 (0.99, 1.01)
  Effect involving only PA (OBE6–12→ MVPA25–29; 
MVPA30–39 →  T2DM40–49) (PSIE-B)
1.01 (1.01, 1.01)
95% CI obtained via bootstrapping.
aMarginal odds ratio.
CI indicates confidence interval; MVPA25–29, moderate-to-vigorous physical activity, 
between age 25 and 29 years; MVPA30–39, moderate-to-vigorous physical activity at age 
30–39 years; OBE30–39, obesity between age 30 and 39 years; PA, short for adult level of 
physical activity; PSDE, path-specific direct effect; PSIE, path-specific indirect effect; 
T2DM40–49, type 2 diabetes at age 40–49 years.
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In a sensitivity analysis, the effect of early obesity on 
adult T2DM risk not due to adult adiposity was much greater 
in individuals who were obese in adolescence compared 
with individuals who were obese in childhood (eFigure 2; 
http://links.lww.com/EDE/B571). Varying the remission 
rates from 0% to 46% had a negligible effect on the “direct” 
and mediated effects of childhood obesity on adult inci-
dent and prevalent T2DM. Likewise, the direct and medi-
ated effects of childhood obesity on adult prevalent T2DM 
was not substantially different from those obtained from the 
analysis of adult incident T2DM (eTables 2–7; http://links.
lww.com/EDE/B571).
DISCUSSION
The purpose of this study was to investigate the overall 
contribution of childhood obesity and racial differences in the 
contribution of childhood obesity to incident adult T2DM. 
Using the g-computation algorithm10 within the virtual cohort 
of Los Angelinos, we consistently examined and quantified the 
pathways through which childhood obesity affected T2DM. 
Our findings suggest that nearly all of the effect attributable to 
childhood obesity in the development of incident T2DM was 
due to pathways other than through adult obesity (so-called 
“direct effect”). In other words, childhood obesity affected the 
risk of incident T2DM but not through adult adiposity, with 
the effect of childhood obesity through adult obesity and adult 
level of physical activity appearing to be minimal in this study. 
In addition, we did not find the presence of racial disparities in 
the effect of childhood obesity on T2DM.
Our findings suggest that childhood obesity could affect 
metabolic health (including insulin resistance) early in life 
and throughout the life course without affecting adult weight. 
In other words, the metabolic disturbances already present in 
childhood34,35 may track from childhood to adulthood without 
affecting adult weight. This would result in adults who have 
normal weight but have metabolic disturbances.36,37 This phe-
notype has sometimes been termed “metabolically unhealthy 
normal weight” (MUNW), with individuals in this phenotype 
being more likely to be male, less physically active, hyper-
tensive, and former smokers compared with normal-weight 
individuals without incident diabetes.36,37 Studies have also 
reported that individuals who were overweight or obese dur-
ing childhood but became normal weight during adulthood 
had a persistent increased risk of adult T2DM compared with 
individuals who were never overweight or obese,2,5 suggesting 
that childhood obesity may have long-term effects that are in-
dependent of its effect on adult obesity. Two plausible mecha-
nisms can explain this phenomenon. First, obesity during 
childhood and adolescence could lead to metabolic changes 
via inflammatory and hormonal pathways through the produc-
tion of adipokines (e.g., tumor necrosis factor α [TNF-α], in-
terleukin-6 [IL-6]), the release of free fatty acids (FFA) from 
adipocyte lipolysis, and the decrease in adiponectin level.38–41 
These changes in turn are responsible for inducing inflamma-
tion and insulin resistance, which have been incriminated in 
the development of T2DM.38–41 When these hormonal and in-
flammatory changes are sustained outside of adult adiposity, 
it could result in T2DM among normal-weight individuals and 
the MUNW phenotype.36,37 Second, other risk factors present 
early in life (i.e., before and during pregnancy and infancy) 
have been suggested to increase the risk of childhood obesity 
in children and T2DM later in life.42–45 These include maternal 
smoking during pregnancy, maternal weight gain, maternal di-
abetes or gestational diabetes, and environmental exposures to 
endocrine-disrupting chemicals.42–45 These factors may play 
a critical role in obesity and diabetes development through 
epigenetic factors and fetal metabolic programming.46–49 Fur-
thermore, metabolic disturbances that occur in childhood and 
more specifically β-cell capacity may be set early in life50 
testifying to their potential to increase T2DM risk throughout 
an individual life course. Further modeling and longitudinal 
studies should consider tracking physiologic changes over the 
life course to better understand the life course causes and con-
sequences of childhood obesity.
Our findings also suggest that childhood obesity could 
also increase the risk of adult adiposity without necessarily 
impacting metabolic health; this could result in the minimal 
effect of childhood obesity on adult T2DM risk from adult ad-
iposity. In other words, the excess weight gain may tract from 
childhood to adulthood4,51,52 without the tracking of the meta-
bolic disturbances. This would result in adults who are obese 
but are “metabolically healthy.”37,53 This phenotype has some-
times been termed “metabolically healthy obese” (MHO) and 
is associated with the non-Hispanic Black race, moderate 
alcohol intake, and higher leisure-time physical activity.37,53 
In fact, it has been shown that the long-term incidence of 
T2DM is reduced in MHO compared with metabolically un-
healthy obese individuals.54 Two phenomena may be at play 
here. First, there is a view (“the adipose tissue expandability” 
FIGURE 2. Proportion of the effect of childhood adiposity on 
adult type 2 diabetes that is mediated through adult adiposity 
by race in ViLA.
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hypothesis55) that stipulates that any excess nutrition or en-
ergy beyond the limit to which adipose tissue can expand will 
be stored as ectopic fat in sites such as muscles.55 According 
to this hypothesis, the metabolic disturbances such as insulin 
resistance would only occur when deposition exceeds the ca-
pacity of the natural adipose tissue stores.55 In other words, 
individuals could gain weight until a certain weight threshold 
but remain metabolically healthy. The second phenomenon 
is related to the inability of BMI to distinguish between fat 
mass and fat-free mass. For instance, a large muscle mass 
(and consequently a high BMI) would likely promote insulin 
sensitivity and protect against the metabolic syndrome.56 This 
would result in individuals with high BMI but normal met-
abolic profile. That is why the use of BMI as a measure of 
adiposity is inadequate in correctly identifying individuals 
and understanding the tracking of metabolic disturbances over 
time.57 In fact, BMI poorly captures body composition (i.e., 
whole-body fat, liver fat, leg fat, visceral fat, skeletal muscle) 
and the ratio of fat mass and fat-free mass (FFM) over time.58 
Further studies should incorporate better physical (e.g., meas-
ures of body fat from Dual Energy X-ray Absorptiometry 
[DXA]), metabolic, and hormonal measures to better assess 
the development of childhood obesity. The existence of the 
MHNW and MHO phenotypes reinforces the notion that the 
natural history of T2DM and its relation with adiposity may 
not be linear over time.58
At first glance, our findings may seem counterintuitive 
given the existing evidence of a positive association between 
childhood obesity and adult obesity4,51,52 and of a positive 
association between adult obesity and adult T2DM.2,5 How-
ever, assuming that there would be a non-null indirect effect 
through adult obesity is not necessarily guaranteed. The rea-
soning behind this expectation is likely based on the “product 
heuristics and method” for mediation analysis.8 The product 
heuristics stipulates that if an exposure A (e.g., childhood 
obesity) affects a mediator M (e.g., adult adiposity) and the 
same mediator M (e.g., adult adiposity) affects an outcome 
Y (e.g., T2DM), then the indirect or mediated effects of A 
on Y through M is roughly equal to the product of the effect 
of A on M and the effect of M on Y. This is not necessarily 
true and one may need to invoke additional assumptions or 
perform a different analysis to consistently estimate the indi-
rect effect using the potential outcomes framework.8,9,31,59 As 
noted by Glynn,8 a more robust analysis may result in a null 
indirect effect even when it appears that there is an indirect 
effect using the product method. Implementing a more robust 
analysis such as using g-computation31,59 requires knowledge 
and proficiency, and this may explain why investigating the 
contribution of childhood obesity to chronic diseases that is 
independent of adult adiposity using such methods has seldom 
been seen in the literature.60
Nonetheless, studies that have attempted to tackle this 
issue have found no effect of childhood obesity on T2DM 
risk that is independent of adult obesity (i.e., no direct effect), 
suggesting that nearly all the increased risk in T2DM due to 
childhood obesity might be due to its effect on adult obesity.60–
64These studies differ from ours in that they have conducted 
their mediation analysis using standard adjustment for adult 
BMI or weight status, a method that is closely related to the 
“difference method.”8,59,65 As mentioned, this simple way of 
adjustment to decompose effects can result in misleading esti-
mates including false null results, especially in the presence 
of heterogeneous effects and interactions, and the threat of 
collider-stratification bias.8,9,66 Because there seems to exist 
a possible interaction between childhood obesity and adult 
obesity in the effect of childhood obesity on T2DM,2,67 these 
estimates based on adjusting for adult BMI could be biased. 
Furthermore, a systematic review also reported inconsistent 
findings,6 and only one study seemed to be in line with our 
current study when adjusting for adult BMI.68 In contrast, 
our study has applied the G-computation algorithm to causal 
mediation analysis and incorporated interactions between ex-
posure and mediator to provide an appropriate and robust es-
timation of effects.31,59
Alternatively, our modeling could have produced artifac-
tual associations if our model calibration did not reflect human 
physiology. In this iteration of the model, we calibrated sub-
sequent variables such that the outcome at time t (e.g., BMIt) 
would be a function of the lagged version of the dependent 
variable (e.g., BMIt−1) and sociodemographics and other vari-
ables (see Table 5 in the adjacent article). This is based on the 
premise that weight gain can track from childhood to adult-
hood,4,51,52 and on the life course perspective.69 This ensures, 
in general, that BMI at a certain time-point would be related to 
BMI at a subsequent time-point (i.e., “short-term” tracking of 
BMI). However, it may not ensure that BMI, say, at time t − 3 
(or time t − 4) would be related to BMI at time t after adjusting 
for other factors (i.e., medium to long-term tracking of BMI). 
This phenomenon should be further explored in longitudinal 
studies to help describe the short, medium, and long-term 
tracking of BMI over the life course. Also, although we have 
strived to calibrate our model to the best of our ability by care-
ful review of the literature (e.g., randomized trials and other 
studies), certain model causal input parameters may be bi-
ased. Despite these potential threats, other simulation models 
such as Archimedes70 and the Cardiovascular Disease Policy 
Model71 have paved the way for incorporating best available 
evidence to replicate the pathophysiology of chronic diseases 
and have been used for informing clinical and policy making.
Additional limitations in this study should be considered. 
First, the use of a virtual cohort as opposed to a real cohort is 
limited by our imperfect replication of the real world. Never-
theless, the model has been validated whenever possible against 
external sources of data representative of Los Angeles County 
and is continuously being updated. Second, our analysis is 
based on a hypothetical birth cohort of Los Angeles County that 
was “born” in 2009 and thus our findings are not generalizable 
to the current U.S. population, but a future population of Los 
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Angeles. Third, another limitation related to the first is that in 
the ViLA-Obesity model, we do not allow for new individuals 
to enter the cohort once it started or for current individuals to 
be lost-to-follow-up, die before the end of follow-up, or experi-
ence competing risks that can prevent them from experiencing 
T2DM in adulthood. In essence, our model assumes that the 
simulated population is closed even though this is not true in the 
real population. Fourth, as mentioned earlier, the use of BMI as 
a measure of adiposity may not support the tracking of body 
fat from childhood to adulthood. Fifth, our model did not in-
clude early life risk factors such as prenatal and neonatal factors 
in this iteration of the model and so was suboptimally param-
etrized to track their effects from childhood to adulthood. In fu-
ture iterations of the ViLA model, we may allow the simulated 
agents to have an offspring so that we can study the prenatal 
and intergenerational effects of obesity on diabetes. Finally, as 
is common in projection studies, our results could be biased 
if our assumptions are different from the real world. The high 
incidence of T2DM we projected could be due to the racially 
diverse composition of Los Angeles County and to the increas-
ing prevalence of obesity. This high incidence in addition to a 
closed population and the fact that the T2DM has been modeled 
as a life-long condition could explain the high prevalence of 
T2DM found in our virtual population. In sensitivity analyses, 
varying the potential remission rate of T2DM due to lifestyle 
and weight loss management with or without medication did 
not substantially impact the effects of childhood obesity on in-
cident or prevalent T2DM that were and were not mediated by 
adult adiposity.
In conclusion, to our knowledge, this study is one of 
the first to use a formal mediation analysis to look at the con-
tribution of childhood obesity on adult T2DM independently 
of adult adiposity. Whether or not childhood obesity impacts 
T2DM through its effect on adult obesity or other mechanisms, 
it is difficult to reverse once established and is a strong marker 
for T2DM.72,73 Therefore, prevention is warranted early in life 
and throughout the life course.74 Our study used a virtual ex-
periment to implement a formal causal mediation analysis and 
illustrated the utility of g-computation for effect decomposi-
tion. As demonstrated in this study, agent-based modeling can 
be used as a virtual laboratory for integrating best available 
knowledge to explore new mechanisms and heterogeneity, test 
novel methods, and generate new hypotheses in obesity and 
diabetes research.
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General Overview of the ViLA Obesity Model 
 The ViLA is a stochastic dynamic discrete-time agent-based computer simulation model 
of obesity and type 2 diabetes incidence and prevalence in the population of Los Angeles 
County. Each agent was born in 2009 in a specific neighborhood of Los Angeles County defined 
by socio-demographics (i.e. proportion of individual self-identified as non-White, the proportion 
of individuals living below the federal poverty level and the proportion of individuals who had a 
bachelor’s degree or higher), physical activity opportunities (i.e. walkability, access to parks), 
food environment (i.e. supermarket, fast-food densities). The agent could exhibit healthy and 
unhealthy behaviors (i.e. breastfeeding, fast-food consumption, sugar-sweetened beverage 
consumption, fresh fruit and vegetable consumption, moderate-to-vigorous physical activity, 
cigarette smoking and alcohol binge drinking). In this synthetic cohort, 98,000 US adults 
residing in Los Angeles were born in 2009 and followed until age 65 in 10 discrete time steps in 
order to study obesity and type 2 diabetes. 
 
Risk functions for incident type 2 diabetes and other endogenous variables 
At each time step, the model updated the individuals’ behaviors, their body mass indices and 
type 2 diabetes status as a function of the agent’s current state. Lifestyle behaviors had a similar 
form and were a function of the behavior in the previous step and the agent’s socio-
demographics. In addition, some behaviors such as physical activity were also a function of the 
neighborhood physical opportunities. BMI and type 2 diabetes were calculated as a function of 
lifestyle behaviors in the previous steps, the BMI at the previous step and the agent’s socio-
demographics. For example, the equation model for type 2 diabetes can be written as follows: 𝑙𝑜𝑔𝑖𝑡𝑃𝑟(𝑌*+, = 1|𝐴*, 𝐴𝑔𝑒*, 𝐶, 𝑌* = 0) = 𝛽7 + 𝛽9*𝐴* + 𝛽9:;*𝐴𝑔𝑒* 	+	𝛽=𝐶		 where Y represents 
type 2 diabetes, A represents lifestyle behaviors and BMI, and C represents time-invariant socio-
demographics. The relative risks (i.e. β’s) were obtained from published evidence and from the 
National Health and Nutrition Examination Survey (NHANES).  (See Appendix 1) 
 
Calibration and Validation  
 The socio-demographics and risk factor distributions for the population and the physical 
environment were pulled from the American Community Survey (ACS), the California Health 
Interview Survey (CHIS), the Centers for Disease Control and Prevention (CDC) and the World 
Health Organization (WHO). The relative risks (i.e. regression coefficients relating any two 
variables) came from published evidence or from parameters computed using publicly and 
privately available data (e.g. American Community Survey, National Establishment Time-Series 
[NETS], Walkscore.com, WHO, National Health and Nutrition Examination Survey 
[NHANES]). (see Appendix table 1) 
 The ViLA Obesity Model was calibrated to be representative of the American population 
residing in Los Angeles, California. This was done through the fine tuning of the baseline risk 
(i.e. intercept) and a subsequent internal validation was accomplished by ensuring that the 
predicted mean outcome approximately matched the observed mean outcome.  
Appendix Table 1. Data sources for the socio-demographics and risk factor distribution  
Socio-demographics and risk factor distribution Data sources 
  
 
 
 
 
Neighborhood socio-demographics (percent non-White, 
percent below federal poverty level, percent bachelor 
graduates graduate or above) 
American Community Survey [1] 
Neighborhood food environment (fast-food density, 
supermarket density) National Establishment Time-Series [2] 
Neighborhood physical activity opportunities (park 
density, walkability) 
National Establishment Time-Series [2] 
Walkscore.com[3]  
Individual socio-demographics (sex, race, income, 
marital status) American Community Survey [1] 
Breastfeeding Centers for Disease Control and Prevention [4] 
Individual behaviors (i.e. fast-food consumption 
Moderate-to-vigorous physical activity, Sugar 
sweetened beverage consumption, Fresh fruit and 
vegetable consumption 
Smoking, Alcohol drinking) 
California Health Interview Survey [5] 
Type 2 diabetes California Health Interview Survey [5] 
Body Mass Index 
WHO[6] 
Los Angeles Health and Nutrition 
Examination Survey [7]   
National Health and Nutrition 
Examination Survey [8] 
  
Appendix Figure 1. Simplified ViLA Model diagram  
The model simulates individuals living in specific simulated neighborhood from birth until age 
65. Each neighborhood is simulated with specified residential makeup, food environment and 
physical activity opportunities. Likewise, simulated individuals have characteristics such as 
socio-demographics, dietary behaviors and physical activity that can affect their subsequent body 
mass index (BMI), obesity and type 2 diabetes risk. 
 
 
Sensitivity Analysis  
 
• Impact of changing the time at which the childhood obesity and adult T2DM were 
assessed on the direct and mediated effects of childhood obesity on incident T2DM 
 
 Appendix Figure 2.  Sensivity analysis for the decomposition of the effect of childhood 
obesity on adult type 2 diabetes in the ViLA-Obesity model.  
The direct effect and the indirect effect represent the pure (PDE) and total effect (TIE) 
respectively. T2DM, Type 2 diabetes 
 
 
• Impact of varying the remission rates of T2DM on the direct and mediated effect of 
childhood obesity on incident and prevalent T2DM 
In the main analysis, we had assumed that T2DM was a life-long condition and that individuals 
who are get T2DM will remain diabetic until the end of follow-up. Given increasing literature 
that remission of T2DM is possible through various means, we conducted a sensitivity analysis 
varying potential remission rates to assess the robustness of our results. We assessed whether the 
direct and mediated effect of childhood obesity on T2DM would be affected if we were to T2DM 
were reversed in its early stages due to lifestyle and medication interventions.[9–11] We did not 
include bariatric surgery because of the high financial associated cost, the long-term 
complications and the fact that not everyone would want to undergo surgery for treating type 2 
diabetes. Most studies defined partial remission rate as having a level of HbA1c between 5.7% 
and 6.5% (i.e. transition from diabetes to prediabetes) and complete remission as having a level 
of HbA1c <5.7% (i.e. normalization of the hyperglycemia without taking any medication). [9–
11] For the purpose of the sensitivity analysis in this study, we defined the remission rate as the 
percent of individuals with T2DM who experience a partial or complete remission of their type 2 
diabetes. In particular, we calculated an “effective remission rate” defined as the percent of 
individuals with T2DM who seek, obtain and comply with the intervention and who experience a 
partial or complete remission of their type 2 diabetes. This is calculated as the remission rate 
times the percent hypothetical uptake of lifestyle and/or medication intervention. This takes into 
account the fact that not every person with type 2 diabetes will successfully seek, obtain and 
comply with the intervention. Essentially, the effective remission rates are as follow: 46%, 35%, 
23%, 12%, 10%, 9%, 8%, 7%, 6%, 5%, 4%, 3%, 2%, 0%. We simulated these remission rates 
among people with type 2 diabetes at each time step starting with time step 4 (Age 18-24) until 
time step 9 (60-65). Since the results were similar when using the joint mediator approach and 
the path-specific approach, we only focused the sensitivity analysis on the pure and controlled 
direct effect of childhood obesity on adult T2DM. We reported the Total Indirect Effect (TIE), 
Pure Direct Effect (PDE), the Total Effect (TE), the Stochastic Controlled Direct (CDEsto) for 
both adult incident and prevalent T2DM. We reported the effects on prevalent T2DM since we 
expected the prevalence of T2DM to be different when applying the remission rates. 
Furthermore, seeing that the biggest change in T2DM prevalence occurred after 40-49, we 
conducted the sensitivity analysis on three outcomes T2DM at 40-49, T2DM at 50-59 and T2DM 
at 60-65. 
As expected, simulating remission among people who had diabetes in ViLA did not alter the 
incidence proportion of T2DM as initially calculated. This was to be expected since we did not 
change the data generating process as far as the incidence of T2DM in the model. Therefore, 
varying the rates of remission of T2DM negligibly impacted the direct and mediated of effects of 
childhood obesity on adult incident T2DM. (See Appendix Table 2 to 4).  We recall here that our 
outcome of interest in the manuscript was incident T2DM defined as the first occurrence of 
T2DM among at-risk individuals. 
However, as expected, varying the remission rate of T2DM would impact the prevalence of 
T2DM in ViLA. Nevertheless, as seen in Appendix Table 5 to 7, when varying the effective 
remission rates from 0% to 46%, the mediated and direct effects of childhood obesity on adult 
prevalent T2DM was not substantially different from those obtained from the analysis of adult 
incident T2DM. This suggested that remission of type 2 diabetes although it had a great impact 
on the prevalence of T2DM, did not substantially impact the direct and mediated effects of 
childhood obesity on both incident and prevalent T2DM. 
 
 
 
 
 
